Aurobindo Pharma arm CuraTeQ Biologics to commercialize proposed biosimilar to Stelara Ruchika Sharma8 July 2023 12:00 PM ISTCuraTeQ intends to file this product in India and Emerging Markets as early as in 2024 and the regulated markets filing is expected to begin in 2026.
Janssen reports positive results from phase 2b FRONTIER 1 trial of JNJ-2113 in plaque psoriasis patients Ruchika Sharma6 July 2023 2:30 PM ISTJNJ-2113 is a novel oral IL-23R antagonist peptide that binds with high affinity to the IL-23R and has properties that allow it to be absorbed with...
Calcipotriol and Calcitriol combo with UV phototherapy effective in Chronic Stable Plaque Psoriasis Dr. Kamal Kant Kohli26 Jun 2023 8:00 PM ISTA recent study published in the journal Photodermatology, Photoimmunology & Photomedicine has demonstrated that the combination therapy of vitamin...
Brodalumab effective in treating Plaque psoriasis, reports study Niveditha Subramani18 Jun 2023 8:00 PM ISTBrodalumab is a monoclonal antibody approved by the United States Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in...
Sun Pharma gets Chinese nod for plaque psoriasis injection Tildrakizumab Ruchika Sharma31 May 2023 11:29 AM ISTILUMETRI is a humanized, anti-IL-23p19 monoclonal antibody designed to selectively block the cytokine IL-23.
Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz Ruchika Sharma22 April 2023 1:30 PM ISTThousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...
Bristol Myers Squibb Sotyktu gets European Commission nod for adults with plaque psoriasis Ruchika Sharma30 March 2023 1:24 PM ISTSotyktu is an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor with a unique mechanism of action, representing a new class of small...
USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz Ruchika Sharma22 March 2023 1:45 PM ISTSandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.
Takeda declares positive results in Phase 2b Study of TAK-279 in people with moderate-to-severe Plaque Psoriasis Ruchika Sharma20 March 2023 3:44 PM ISTPsoriasis is a chronic autoimmune disease in which the body's immune system causes skin cells to multiply too quickly.
Tapinarof cream shown to be beneficial in atopic dermatitis patients as young as 2 years old: ADORING 2 trial Dr. Kamal Kant Kohli17 March 2023 7:45 PM ISTUSA: Topical VTAMA (tapinarof) cream was shown to be safe and effective in pediatric subjects down to 2 years old and adult subjects with atopic...
Goselkumab therapy beneficial for patients with moderate to severe plaque psoriasis Aditi31 Jan 2023 9:45 AM ISTUSA: A research report of a real-world study published in Dermatology and Therapy has concluded that patients with moderate-to-severe plaque...
Sponsor should submit rescue management plan: CDSCO Panel Tells Sun Pharma Over Psoriasis Drug Tildrakizumab Susmita Roy18 Jan 2023 6:00 PM ISTNew Delhi: Granting the permission to conduct the proposed study of Tildrakizumab 100mg/ml, the Subject Expert Committee (SEC) functional under the...
